FIELD: medicine and pharmaceutical chemistry. SUBSTANCE: agent contains L-alanine, L- arginine, L-valine, L-histidine, L-isoleucine, glycin, L-leucine, L-lysine, L- proline, L-treon, L-phenylalanine, L-cysteine, polyvinylpyrrolidone with molecular weight 8000+/-2000, D-sorbitol, and injection water. Solution has pH 6.0-6.8. EFFECT: achieved anabolic effect with enhanced detoxification properties due to excretion of toxic substances through kidney barrier and also stabilized amino acid balance.
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT FOR PARENTERAL NUTRITION AND DISINTOXICATION | 1992 |
|
RU2017489C1 |
MEDICINAL SUBSTANCE | 0 |
|
SU1438793A1 |
MEDICAL AGENT "POLYAMIN" | 0 |
|
SU728861A1 |
MEDICINAL AGENT FOR PREVENTING AND/OR TREATING HEPATOCELLULAR CARCINOMA | 2011 |
|
RU2574009C2 |
EMULSION OF PERFLUORO-GANIC COMPOUNDS WITH INCREASED OXYGEN CAPACITY | 2022 |
|
RU2803466C2 |
SHRIMP FOOD PROTEIN PRODUCT MANUFACTURE METHOD | 2013 |
|
RU2554994C2 |
BIOLOGICALLY ACTIVE FOOD ADDITIVE | 2002 |
|
RU2222996C1 |
PHARMACEUTICAL COMPOSITION FOR PARENTERAL DROP INTRODUCTION | 2019 |
|
RU2721605C1 |
PHARMACEUTICAL COMPOSITION FOR PARENTERAL DRIP INTRODUCTION | 2019 |
|
RU2709502C1 |
SERUM-FREE NUTRIENT MEDIUM FOR CULTURING MDCK OR VERO CELLS OR VACCINE STRAINS OF MEASLES OR INFLUENZA VIRUSES | 2018 |
|
RU2703826C1 |
Authors
Dates
2001-10-27—Published
2001-03-13—Filed